Aclarion, Inc. income statement

In fiscal 2025, Aclarion, Inc. reported revenue of $75,730, up 65.6% on the year before, operating income of −$7.1m (a -9312.5% margin) and net income of −$7.2m, or −$13.61 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Aclarion, Inc.: income statement, annual
Fiscal year	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMJun 2026
Revenue	60	60	75	46	76	84
Cost of revenue	69	65	76	85	69	66
Gross profit	−9	−5	−0	−39	7	18
Research and development	788	1,068	873	889	1,034	1,178
Selling and marketing	331	498	757	977	1,901	3,040
General and administrative	1,825	3,991	3,245	3,609	4,125	5,511
Operating income	−2,953	−5,562	−4,876	−5,513	−7,052	−9,711
Interest expense	475	1,508	111	64	—	—
Income before tax	—	−7,069	−4,911	−6,993	−7,234	−9,197
Income tax	0	0	0	0	0	0
Net income	−4,950	−7,069	−4,911	−6,993	−7,234	−9,197
Diluted EPS	−$0.44	−$1.31	−$5318.80	−$7478.90	−$13.61	—
Diluted shares (average)	14m	6m	—	—	—	—
EBITDA	−2,767	−5,418	−4,713	−5,320	−6,825	−9,529

US$ thousands unless shown otherwise. Fiscal quarters.

Aclarion, Inc.: income statement, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Revenue	14	10	19	19	19	18	21	25
Cost of revenue	21	21	23	14	15	17	17	17
Gross profit	−7	−10	−4	5	4	2	4	8
Research and development	196	252	198	270	302	263	315	297
Selling and marketing	233	338	303	344	632	622	909	877
General and administrative	860	1,206	987	1,127	901	1,110	1,766	1,734
Operating income	−1,296	−1,806	−1,492	−1,737	−1,831	−1,993	−2,987	−2,900
Income before tax	−1,366	−1,990	−2,037	−1,601	−1,706	−1,889	−2,854	−2,748
Income tax	0	0	0	0	0	0	0	0
Net income	−1,366	−1,990	−2,037	−1,601	−1,706	−1,889	−2,854	−2,748
Diluted EPS	−$1321.49	−$1585.25	−$9.32	−$2.75	−$2.93	−$2.01	−$1.34	−$1.12
EBITDA	−1,246	−1,754	−1,437	−1,736	−1,773	−1,932	−2,926	−2,898

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: ACON vs ISPC ACON vs YDES ACON vs QSI

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Aclarion, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Aclarion, Inc.